Ki | 600 nM | Cytochrome P450 19A1 | P11511 | |
IC50 | 10000 nM | Cytochrome P450 3A4 | P08684 | |
Others | 0.166 Amax nM-1 | Cytochrome P450 19A1 | P11511 | |
IC50 | 3.9 nM | Androgen Receptor | P10275 | |
Ki | 100000 nM | 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Q15125 | |
IC50 | 10000 nM | Estrogen receptor alpha | P03372 | |
IC50 | 2.7 nM | Androgen Receptor | P10275 | |
IC50 | 10000 nM | Estrogen receptor beta | Q92731 | |
IC50 | 14 nM | Testis-specific androgen-binding protein | P04278 | |
Others | 72 % | Androgen Receptor | P10275 | |
Others | 95 % | Androgen Receptor | P10275 | |
IC50 | 10000 nM | Estrogen receptor alpha | P03372 | |
IC50 | 10000 nM | Estrogen receptor beta | Q92731 | |
IC50 | 10000 nM | Estrogen receptor beta | Q92731 | |
EC50 | 18300 nM | G-protein coupled bile acid receptor 1 | Q8TDU6 | |
IC50 | 50000 nM | Cytochrome P450 51 | Q16850 | |
Kd | 0.631 nM | Testis-specific androgen-binding protein | P04278 | |
Others | 6 % | Androgen Receptor | P10275 | |
Others | 41.1 % | Cytochrome P450 3A4 | P08684 | |
Others | 10.5 % | Cytochrome P450 3A4 | P08684 | |
Others | 4.38 % | Cytochrome P450 3A4 | P08684 | |
Others | 61 % | Cytochrome P450 3A4 | P08684 | |
Others | 10.4 % | Cytochrome P450 3A4 | P08684 | |
Others | 4.85 % | Cytochrome P450 3A4 | P08684 | |
Others | 69.4 % | Cytochrome P450 3A4 | P08684 | |
Others | 7.96 % | Cytochrome P450 3A4 | P08684 | |
Others | 11.46 % | Cytochrome P450 3A4 | P08684 | |
Others | 44.1 % | Cytochrome P450 3A4 | P08684 | |
Others | 7.82 % | Cytochrome P450 3A4 | P08684 | |
Others | 7.04 % | Cytochrome P450 3A4 | P08684 | |
Others | 103 % | Cytochrome P450 3A4 | P08684 | |
Others | 69.6 % | Cytochrome P450 3A4 | P08684 | |
Others | 69.7 % | Cytochrome P450 3A4 | P08684 | |
Others | 95 % | Cytochrome P450 3A4 | P08684 | |
Others | 98.7 % | Cytochrome P450 3A4 | P08684 | |
Others | 97.1 % | Cytochrome P450 3A4 | P08684 | |
Others | 140 % | Canalicular multispecific organic anion transporter 1 | Q92887 | |
EC50 | 3.162 nM | Androgen Receptor | P10275 | |
Others | 7.5 % | 3-keto-steroid reductase | P56937 | |
Potency | 5623.4 nM | Prelamin-A/C | P02545 | |
Potency | 31622.8 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 31.6 nM | Thyroid stimulating hormone receptor | P16473 | |
Potency | 31.6 nM | Thyroid stimulating hormone receptor | P16473 | |
Potency | 31622.8 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 12589.3 nM | Beta-glucocerebrosidase | P04062 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 1-1 | P22309 | |
Others | 8 total picomoles | UDP-glucuronosyltransferase 2B7 | P16662 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 1-1 | P22309 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 1-10 | Q9HAW8 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 1-10 | Q9HAW8 | |
Others | 4 pm/min/mg | UDP-glucuronosyltransferase 1A4 | P22310 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 1-6 | P19224 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 1-7 | Q9HAW7 | |
Others | 20 pm/min/mg | UDP-glucuronosyltransferase 1-8 | Q9HAW9 | |
Others | 207 pm/min/mg | UDP-glucuronosyltransferase 2A1 | Q9Y4X1 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 2B10 | P36537 | |
Others | 4 pm/min/mg | UDP-glucuronosyltransferase 2B15 | P54855 | |
Others | 9 pm/min/mg | UDP-glucuronosyltransferase 2B17 | O75795 | |
Others | 9 pm/min/mg | UDP-glucuronosyltransferase 2B17 | O75795 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 2B4 | P06133 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 2B4 | P06133 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 2B4 | P06133 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 2B4 | P06133 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 2B7 | P16662 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 2B7 | P16662 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 2B7 | P16662 | |
Others | 2 | Cytochrome P450 2C9 | P11712 | |
Potency | 66824.2 nM | Nuclear factor erythroid 2-related factor 2 | Q16236 | |
Potency | 730.8 nM | Geminin | O75496 | |
Potency | 74978 nM | Interleukin-8 | P10145 | |
Potency | 26603.2 nM | Nuclear receptor ROR-gamma | P51449 | |
IC50 | 4.571 nM | Androgen Receptor | P10275 | |
Others | 0.1 % | Androgen Receptor | P10275 | |
Others | 100 % | Androgen Receptor | P10275 | |
Others | -175.1 % | Solute carrier organic anion transporter family member 2B1 | O94956 | |
Others | 37.4 % | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | |
Others | 33.2 % | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | |
Others | 2 % | Androgen Receptor | P10275 | |
Others | 100 % | Androgen Receptor | P10275 | |
Others | 100 % | Androgen Receptor | P10275 | |
IC50 | 4.17 nM | Androgen Receptor | P10275 | |
IC50 | 4.27 nM | Androgen Receptor | P10275 | |
IC50 | 34 nM | Voltage-gated L-type calcium channel alpha-1C subunit | Q13936 | |
IC50 | 38.4 nM | Voltage-gated L-type calcium channel alpha-1C subunit | Q13936 | |